犬用ワクチンの世界市場レポート 2025年

犬用ワクチンの市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.5％で50億8,000万米ドルに成長します。予測期間の成長は、ペットの飼育率の増加、飼い主の健康意識、政府の規制と義務化、ペットの人間化の高まり、イヌの病気の流行に起因します。予測期間の主な動向には、ペット保険やヘルスケアプラン、入手のしやすさ、カスタマイズされたワクチン接種プロトコル、疾病パターンの変化、新規ワクチンの開発などがあります。

ペット犬の普及が今後の犬用ワクチン市場の成長を牽引すると予測されます。ペット犬とは、家庭で飼われている、または飼いならされたコンパニオンアニマルと定義されます。犬用ワクチンは、子犬の段階から成犬になるまで、段階ごとに投与される注射です。これらのワクチンは免疫系を刺激し、犬が病気を回避したり、症状が軽くなったりするのを助けます。例えば、米国の非営利業界団体である米国ペット用品協会が2021年から2022年にかけて実施した「全米ペット飼育者調査」によると、米国では70％の世帯がペットを飼育しており、これは9,050万世帯に相当します。このうち、犬をペットとして飼っている世帯は6,900万世帯で、他の種類のペットに比べて最も多い数です。このように、ペット犬の普及が犬用ワクチン市場の成長に寄与しています。

人獣共通感染症の流行が増加していることが、今後の犬用ワクチン市場の成長を促進すると予測されています。人獣共通感染症は、ズーノーシスとも呼ばれ、動物と人間の間で自然に感染する感染症であり、その逆の場合もあります。犬用ワクチンは、犬から人への人獣共通感染症の伝播を防ぐために不可欠であり、人獣共通感染症の制御と管理を目的とした公衆衛生の取り組みにおいて重要な役割を果たしています。例えば、米国を拠点とする独立系超党派シンクタンクで出版社でもある外交問題評議会（CFR）は2023年2月、新たに発見された感染症や新興感染症（EID）の最大75％、認知されている感染症の60％が人獣共通感染症を起源としていると報告しました。人獣共通感染症により、世界全体で年間25億人が発症し、270万人が死亡しています。このように、人獣共通感染症の流行が、犬用ワクチン市場の成長を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の犬用ワクチン市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の犬用ワクチン市場：成長率分析
• 世界の犬用ワクチン市場の実績：規模と成長、2019～2024年
• 世界の犬用ワクチン市場の予測：規模と成長、2024～2029年、2034年
• 世界の犬用ワクチン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の犬用ワクチン市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 弱毒生ワクチン
• 結合ワクチン
• 不活化ワクチン
• サブユニットワクチン
• トキソイドワクチン
• DNAワクチン
• 組換えワクチン
• 世界の犬用ワクチン市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 皮下
• 筋肉内
• 鼻腔内
• 世界の犬用ワクチン市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 6ヶ月未満
• 6ヶ月以上
• 世界の犬用ワクチン市場：弱毒生ワクチンのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 犬パルボウイルスワクチン
• 犬ジステンパーワクチン
• 犬アデノウイルスワクチン
• 世界の犬用ワクチン市場：結合ワクチンのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 犬レプトスピラワクチン
• 犬ボルデテラワクチン
• 世界の犬用ワクチン市場：不活化ワクチンのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 犬パルボウイルスワクチン
• 犬インフルエンザワクチン
• 世界の犬用ワクチン市場：サブユニットワクチンのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 犬ライム病ワクチン
• 犬パラインフルエンザワクチン
• 世界の犬用ワクチン市場：トキソイドワクチンのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 犬レプトスピラ症トキソイドワクチン
• 世界の犬用ワクチン市場：DNAワクチンのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 犬黒色腫ワクチン
• 世界の犬用ワクチン市場：組換えワクチンのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 犬ライム病組換えワクチン
• 犬用ボルデテラ組換えワクチン

第7章 地域別・国別分析

• 世界の犬用ワクチン市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の犬用ワクチン市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 犬用ワクチン市場：競合情勢
• 犬用ワクチン市場：企業プロファイル
  • Vetoquinol S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis
  • Heska Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Virbac Animal Health Pvt. Ltd.
• Elanco Animal Health Incorporated
• Zoetis Inc.
• CZ Vaccines
• Indian Immunologicals Ltd.
• Meiji Holdings Co. Ltd.
• Bioveta A.S.
• Phibro Animal Health Corporation
• Hester Biosciences Limited
• High Speed Digieal Processor Architecture Pvt. Ltd.
• Dechra Pharmaceuticals PLC
• Norbrook Inc.
• Biogenesis Bago SA
• Vaxxinova India Private Limited
• Bimeda Animal Health Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 犬用ワクチン市場2029年：新たな機会を提供する国
• 犬用ワクチン市場2029年：新たな機会を提供するセグメント
• 犬用ワクチン市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Dog vaccines constitute a series of administered injections, commencing during the puppy stage and extending into adulthood. These vaccines aim to introduce small amounts of a virus particle to trigger an immune response in the dog's body. This proactive measure enables the dog to mount an immune defense in the event of exposure to bacteria or viruses, thereby preventing illness.

Key categories of dog vaccines encompass attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines. Attenuated live vaccines involve creating a vaccine by reducing the virulence of a pathogen while maintaining its viability. Administration methods include subcutaneous, intramuscular, and intranasal routes, catering to dogs below 6 months and those above 6 months.

The dog vaccines market research report is one of a series of new reports from The Business Research Company that provides dog vaccines market statistics, including dog vaccines industry global market size, regional shares, competitors with an dog vaccines market share, detailed dog vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the dog vaccines industry. This dog vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dog vaccines market size has grown strongly in recent years. It will grow from $3.61 billion in 2024 to $3.81 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to innovative vaccination protocols, zoonotic disease awareness, globalization and travel, educational campaigns, research and vaccine development, veterinary practice evolution.

The dog vaccines market size is expected to see strong growth in the next few years. It will grow to $5.08 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to increasing pet adoption rates, health consciousness among pet owners, government regulations and mandates, rising humanization of pets, prevalence of canine diseases. Major trends in the forecast period include pet insurance and healthcare plans, availability and accessibility, customized vaccination protocols, changing disease patterns, development of novel vaccines.

The increasing adoption of pet dogs is anticipated to drive the growth of the dog vaccines market in the future. A pet dog is defined as a domesticated or tamed companion animal that lives in a household. Dog vaccines are injections administered in a series, beginning in the puppy stage and continuing into adulthood. These vaccines stimulate the immune system, helping dogs to confront microorganisms and either avoid illness or experience less severe symptoms. For example, according to the National Pet Owners Survey conducted by the American Pet Products Association for 2021-2022, a US-based non-profit industry association, 70% of households in the United States owned a pet, equating to 90.5 million homes. Among these, 69 million U.S. households had a dog as a pet, the highest number compared to other types of pets. Therefore, the rise in the adoption of pet dogs is contributing to the growth of the dog vaccines market.

The increasing prevalence of zoonotic diseases is projected to drive the growth of the dog vaccines market in the future. Zoonotic diseases, also referred to as zoonoses, are infectious diseases that can be transmitted naturally between animals and humans and vice versa. Dog vaccines are essential in preventing the transmission of zoonotic diseases from dogs to humans and play a significant role in public health initiatives aimed at controlling and managing zoonotic infections. For example, in February 2023, the Council on Foreign Relations (CFR), a US-based independent, nonpartisan think tank and publisher, reported that up to 75% of newly discovered or emerging infectious diseases (EIDs) and 60% of recognized infectious diseases have zoonotic origins. Globally, zoonoses result in 2.7 million human deaths and 2.5 billion instances of disease annually. Thus, the increasing prevalence of zoonotic diseases is fueling the growth of the dog vaccines market.

Technological advancements are emerging as a prominent trend in the dog vaccines market. Leading companies in the market are leveraging novel technologies for vaccine development. Merck Animal Health, a notable player, introduced Nobivac Intra-Trac Oral BbPi in September 2022. This oral vaccine, featuring mucosal protection and easy administration, represents a technological leap forward. It employs the innovative Immuno-Mist-R technology by Intervet, a Merck & Co subsidiary, significantly enhancing mucosal surface area contact. This technological progress in vaccine development contributes to the effectiveness and ease of administration in the dog vaccines market.

Major companies in the dog vaccines market are concentrating on innovative rabies vaccines to gain a competitive edge. The introduction of a three-dose rabies vaccine by Cadila Pharmaceuticals exemplifies this focus on innovation. Launched in April 2022, ThRabis is a recombinant nanoparticle-based rabies G protein vaccine, utilizing virus-like particle technology. The vaccine, generated from cloned genes expressed in insect cells, neutralizes the rabies virus and prevents its attachment to cells. This innovation in rabies vaccines addresses key aspects of effectiveness, accessibility, and administration, positioning companies at the forefront of the competitive landscape in the dog vaccines market.

In September 2024, Boehringer Ingelheim, a Germany-based company active in both the human and animal health sectors, acquired Saiba Animal Health AG for an undisclosed sum. This acquisition bolsters Boehringer Ingelheim's research and development capabilities in the animal health sector, with a particular emphasis on innovative therapeutic vaccines for pets that target chronic diseases like allergies, inflammation, and pain. Saiba Animal Health AG is a Switzerland-based company that specializes in providing dog vaccines.

Major companies operating in the dog vaccines market are Vetoquinol S.A., Boehringer Ingelheim GmbH, Ceva Sante Animale, Heska Corporation, Merck & Co. Inc., Virbac Animal Health Pvt. Ltd., Elanco Animal Health Incorporated, Zoetis Inc., CZ Vaccines, Indian Immunologicals Ltd., Meiji Holdings Co. Ltd., Bioveta A.S., Phibro Animal Health Corporation, Hester Biosciences Limited, High Speed Digieal Processor Architecture Pvt. Ltd., Dechra Pharmaceuticals PLC, Norbrook Inc., Biogenesis Bago SA, Vaxxinova India Private Limited, Bimeda Animal Health Ltd., Lohmann Animal Health GmbH, Biovac Ltd., Zenex Animal Health India Pvt. Ltd., Instituto Rosenbusch S A

Asia-Pacific was the largest region in the dog vaccines market in 2024. The regions covered in the dog vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dog vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dog vaccines market consists of sales of vaccines for dogs including core dog vaccines, and non-core dog vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dog Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dog vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dog vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dog vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Attenuated Live Vaccines; Conjugate Vaccines; Inactivated Vaccines; Subunit Vaccines; Toxoid Vaccines; DNA Vaccines; Recombinant Vaccines
• 2) By Route Of Administration: Subcutaneous; Intramuscular; Intranasal
• 3) By Application: Below 6 Months; Above 6 Months
• Subsegments:
• 1) By Attenuated Live Vaccines: Canine Parvovirus Vaccine; Canine Distemper Vaccine; Canine Adenovirus Vaccine
• 2) By Conjugate Vaccines: Canine Leptospira Vaccine; Canine Bordetella Vaccine
• 3) By Inactivated Vaccines: Canine Parvovirus Vaccine; Canine Influenza Vaccine
• 4) By Subunit Vaccines: Canine Lyme Disease Vaccine; Canine Parainfluenza Vaccine
• 5) By Toxoid Vaccines: Canine Leptospirosis Toxoid Vaccine
• 6) By DNA Vaccines: Canine Melanoma Vaccine
• 7) By Recombinant Vaccines: Canine Lyme Disease Recombinant Vaccine; Canine Bordetella Recombinant Vaccine
• Companies Mentioned: Vetoquinol S.A.; Boehringer Ingelheim GmbH; Ceva Sante Animale; Heska Corporation; Merck & Co. Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dog Vaccines Market Characteristics

3. Dog Vaccines Market Trends And Strategies

4. Dog Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Dog Vaccines Growth Analysis And Strategic Analysis Framework

• 5.1. Global Dog Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Dog Vaccines Market Growth Rate Analysis
• 5.4. Global Dog Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Dog Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Dog Vaccines Total Addressable Market (TAM)

6. Dog Vaccines Market Segmentation

• 6.1. Global Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Attenuated Live Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• DNA Vaccines
• Recombinant Vaccines
• 6.2. Global Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Subcutaneous
• Intramuscular
• Intranasal
• 6.3. Global Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Below 6 Months
• Above 6 Months
• 6.4. Global Dog Vaccines Market, Sub-Segmentation Of Attenuated Live Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Canine Parvovirus Vaccine
• Canine Distemper Vaccine
• Canine Adenovirus Vaccine
• 6.5. Global Dog Vaccines Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Canine Leptospira Vaccine
• Canine Bordetella Vaccine
• 6.6. Global Dog Vaccines Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Canine Parvovirus Vaccine
• Canine Influenza Vaccine
• 6.7. Global Dog Vaccines Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Canine Lyme Disease Vaccine
• Canine Parainfluenza Vaccine
• 6.8. Global Dog Vaccines Market, Sub-Segmentation Of Toxoid Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Canine Leptospirosis Toxoid Vaccine
• 6.9. Global Dog Vaccines Market, Sub-Segmentation Of DNA Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Canine Melanoma Vaccine
• 6.10. Global Dog Vaccines Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Canine Lyme Disease Recombinant Vaccine
• Canine Bordetella Recombinant Vaccine

7. Dog Vaccines Market Regional And Country Analysis

• 7.1. Global Dog Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Dog Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dog Vaccines Market

• 8.1. Asia-Pacific Dog Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dog Vaccines Market

• 9.1. China Dog Vaccines Market Overview
• 9.2. China Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dog Vaccines Market

• 10.1. India Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dog Vaccines Market

• 11.1. Japan Dog Vaccines Market Overview
• 11.2. Japan Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dog Vaccines Market

• 12.1. Australia Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dog Vaccines Market

• 13.1. Indonesia Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dog Vaccines Market

• 14.1. South Korea Dog Vaccines Market Overview
• 14.2. South Korea Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dog Vaccines Market

• 15.1. Western Europe Dog Vaccines Market Overview
• 15.2. Western Europe Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dog Vaccines Market

• 16.1. UK Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dog Vaccines Market

• 17.1. Germany Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dog Vaccines Market

• 18.1. France Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dog Vaccines Market

• 19.1. Italy Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dog Vaccines Market

• 20.1. Spain Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dog Vaccines Market

• 21.1. Eastern Europe Dog Vaccines Market Overview
• 21.2. Eastern Europe Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dog Vaccines Market

• 22.1. Russia Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dog Vaccines Market

• 23.1. North America Dog Vaccines Market Overview
• 23.2. North America Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dog Vaccines Market

• 24.1. USA Dog Vaccines Market Overview
• 24.2. USA Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dog Vaccines Market

• 25.1. Canada Dog Vaccines Market Overview
• 25.2. Canada Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dog Vaccines Market

• 26.1. South America Dog Vaccines Market Overview
• 26.2. South America Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dog Vaccines Market

• 27.1. Brazil Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dog Vaccines Market

• 28.1. Middle East Dog Vaccines Market Overview
• 28.2. Middle East Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dog Vaccines Market

• 29.1. Africa Dog Vaccines Market Overview
• 29.2. Africa Dog Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Dog Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Dog Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dog Vaccines Market Competitive Landscape And Company Profiles

• 30.1. Dog Vaccines Market Competitive Landscape
• 30.2. Dog Vaccines Market Company Profiles
  • 30.2.1. Vetoquinol S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Heska Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Dog Vaccines Market Other Major And Innovative Companies

• 31.1. Virbac Animal Health Pvt. Ltd.
• 31.2. Elanco Animal Health Incorporated
• 31.3. Zoetis Inc.
• 31.4. CZ Vaccines
• 31.5. Indian Immunologicals Ltd.
• 31.6. Meiji Holdings Co. Ltd.
• 31.7. Bioveta A.S.
• 31.8. Phibro Animal Health Corporation
• 31.9. Hester Biosciences Limited
• 31.10. High Speed Digieal Processor Architecture Pvt. Ltd.
• 31.11. Dechra Pharmaceuticals PLC
• 31.12. Norbrook Inc.
• 31.13. Biogenesis Bago SA
• 31.14. Vaxxinova India Private Limited
• 31.15. Bimeda Animal Health Ltd.

32. Global Dog Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dog Vaccines Market

34. Recent Developments In The Dog Vaccines Market

35. Dog Vaccines Market High Potential Countries, Segments and Strategies

• 35.1 Dog Vaccines Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Dog Vaccines Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Dog Vaccines Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer